TFF Pharmaceuticals Inc (TFFP)
0.3761
-1.22
(-76.49%)
USD |
NASDAQ |
Nov 15, 16:00
0.3651
-0.01
(-2.92%)
After-Hours: 20:00
TFF Pharmaceuticals Total Liabilities (Quarterly): 3.618M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 3.618M |
March 31, 2024 | 3.882M |
December 31, 2023 | 2.460M |
September 30, 2023 | 1.194M |
June 30, 2023 | 1.287M |
March 31, 2023 | 1.668M |
December 31, 2022 | 1.241M |
September 30, 2022 | 2.205M |
June 30, 2022 | 3.974M |
March 31, 2022 | 2.197M |
December 31, 2021 | 1.961M |
Date | Value |
---|---|
September 30, 2021 | 1.558M |
June 30, 2021 | 1.534M |
March 31, 2021 | 1.817M |
December 31, 2020 | 1.322M |
September 30, 2020 | 1.573M |
June 30, 2020 | 0.6898M |
March 31, 2020 | 1.205M |
December 31, 2019 | 1.543M |
September 30, 2019 | 2.188M |
June 30, 2019 | 1.624M |
December 31, 2018 | 1.157M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.6898M
Minimum
Jun 2020
3.974M
Maximum
Jun 2022
1.944M
Average
1.573M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
Eyenovia Inc | 21.36M |
NovaBay Pharmaceuticals Inc | 2.805M |
Palatin Technologies Inc | 10.85M |
iBio Inc | 7.41M |
Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 9.496M |
Shareholders Equity (Quarterly) | 5.877M |
Current Ratio | 1.625 |